G&A at other companies
Other financials
Where this comes from
Reported directly by Tectonic Therapeutics in its filing.
Tagged under the XBRL concept us-gaap:GeneralAndAdministrativeExpense.
The official record: Tectonic Therapeutics’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Tectonic Therapeutics's g&a.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Tectonic Therapeutics's G&A?
- Tectonic Therapeutics (TECX) reported G&A of $6.43M in Q1 2026.
- How has Tectonic Therapeutics's G&A changed year-over-year?
- Tectonic Therapeutics's G&A increased by 22.2% year-over-year, from $5.26M to $6.43M.
- What is the long-term trend for Tectonic Therapeutics's G&A?
- Over 4 years (2021 to 2025), Tectonic Therapeutics's G&A has grown at a -12.9% compound annual growth rate (CAGR), from $35.73M to $20.55M.
- What does G&A mean?
- Overhead costs not directly tied to production or sales — corporate management, legal, accounting, office rent, insurance, and other administrative functions.